bioAffinity Technologies (BIAFW) News Today $0.21 +0.01 (+2.95%) As of 05/22/2026 03:39 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BIAFW Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period bioAffinity Technologies (NASDAQ:BIAFW) Stock Price Down 23.6% - Should You Sell?May 13, 2026 | americanbankingnews.combioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual "Advances in Early Lung Cancer Detection" Symposium April 16April 7, 2026 | finance.yahoo.combioAffinity Technologies' CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026April 1, 2026 | tmcnet.comBioAffinity Technologies stock cools off after strong Friday rally - here's whyMarch 16, 2026 | msn.combioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath(R) LungMarch 13, 2026 | marketwatch.combioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung ...February 25, 2026 | finance.yahoo.combioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory BoardFebruary 9, 2026 | finance.yahoo.combioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) AccreditationJanuary 7, 2026 | finance.yahoo.combioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer RoundtableDecember 3, 2025 | finance.yahoo.comEarnings roundup: Q3 rocky for bioAffinity and Spurs concessionaireNovember 25, 2025 | msn.combioAffinity Technologies Regains Compliance with Nasdaq Listing RequirementsOctober 15, 2025 | finance.yahoo.combioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq RulesOctober 9, 2025 | finance.yahoo.comBioAffinity's lung cancer test sales soar 95% as veterans' hospitals drive adoptionOctober 7, 2025 | bizjournals.combioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025October 7, 2025 | finance.yahoo.comBioAffinity Technologies files to sell 729,927 shares of common stockSeptember 24, 2025 | msn.combioAffinity Technologies Inc trading halted, news pendingSeptember 19, 2025 | msn.comU.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VASeptember 3, 2025 | finance.yahoo.combioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test SalesAugust 13, 2025 | finance.yahoo.comCase Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test ResultsJuly 29, 2025 | finance.yahoo.comCase Study: CyPath® Lung Detects Neuroendocrine Tumor Missed by Other Diagnostic ToolsJuly 24, 2025 | finance.yahoo.comCanada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer DiagnosticJuly 22, 2025 | finance.yahoo.combioAffinity Technologies Secures Chinese Patent for Lung Cancer DetectionJuly 15, 2025 | tipranks.combioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer DiagnosticJuly 15, 2025 | finance.yahoo.combioAffinity Technologies, Inc. (BIAF) - Yahoo FinanceJune 27, 2025 | finance.yahoo.combioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer TherapyJune 24, 2025 | finance.yahoo.combioAffinity Technologies Enters Sales Agreement with WallachBethMay 27, 2025 | tipranks.combioAffinity Technologies names new chief medical officerMay 22, 2025 | uk.investing.combioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical OfficerMay 21, 2025 | uk.finance.yahoo.combioAffinity Technologies Reports First Quarter 2025 ResultsMay 17, 2025 | seekingalpha.combioAffinity Technologies Completes $3.2M Public OfferingMay 8, 2025 | tipranks.comIndependent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung CancerMay 8, 2025 | finance.yahoo.comThe Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity TechnologiesMay 7, 2025 | uk.finance.yahoo.combioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit CostApril 17, 2025 | tmcnet.combioAffinity Technologies Reports Record Revenue for 2024April 7, 2025 | tipranks.com3BIAF : What's Going On With BioAffinity Shares Tuesday?April 1, 2025 | benzinga.comCase Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer RecurrenceMarch 19, 2025 | finance.yahoo.comPhysicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung CancerMarch 14, 2025 | finance.yahoo.comBioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLSMarch 6, 2025 | markets.businessinsider.combioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales GrowthMarch 6, 2025 | tmcnet.combioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 MillionFebruary 27, 2025 | tmcnet.comWallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 MillionFebruary 27, 2025 | finance.yahoo.combioAffinity secures Australian patent for lung cancer testJanuary 22, 2025 | msn.combioAffinity Technologies stock hits 52-week low at $0.65January 21, 2025 | msn.comBiotech company CEO receives pay bumpJanuary 18, 2025 | bizjournals.combioAffinity Technologies Adjusts CEO Compensation PackageJanuary 14, 2025 | tipranks.combioAffinity Technologies, Inc. (BIAFW)December 22, 2024 | nz.finance.yahoo.combioAffinity Technologies Boosts Sales with CyPath LungDecember 20, 2024 | tipranks.comJoin bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19December 17, 2024 | finance.yahoo.combioAffinity Technologies Set for Continued Expansion in 2025December 12, 2024 | finance.yahoo.comVeterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply ScheduleDecember 5, 2024 | finance.yahoo.com Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIAFW Media Mentions By Week BIAFW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAFW News Sentiment▼0.000.44▲Average Medical News Sentiment BIAFW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAFW Articles This Week▼01▲BIAFW Articles Average Week Get the Latest News and Ratings for BIAFW and Related Stocks Enter your email address to receive the latest news and analysts' ratings for bioAffinity Technologies and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies DTSTW News Today FTAIN News Today FTAIM News Today GRABW News Today SWVLW News Today BABA News Today UBER News Today PDD News Today SPGI News Today MELI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAFW) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
